Fungal infections in transplant recipients: pros and cons of immunosuppressive and antimicrobial treatment
Year: 2021
Type: article
Abstract: The continuing increase in the number of patients treated with transplantation procedures is attested by a worldwide activity of more than 150 000 grafts per year, including solid-organ transplants and haematopoietic stem-cell transplants.1,2 Recipients of solid-organ transplants or haematopoietic stem-cell transplants are exposed to various types of complications, including rejection (mainly graft-versus-host disease) and infectious diseases (especially bacterial, viral, and fungal infections, and occasionally protozoal infections).
Source: The Lancet Microbe
Institutions: Université de Bretagne Occidentale, Université d'Angers, Centre Hospitalier Régional Universitaire de Brest, École des Hautes Études en Santé Publique, Institut de Recherche en Santé, Environnement et Travail, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Université de Rennes, Inserm, Centre Hospitalier Universitaire d'Angers, University of Cologne, German Center for Infection Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, Manchester Academic Health Science Centre, University of Manchester
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W3118251244
